Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q3 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading insider activity...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Ranked against 13 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-09-30.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NWS | $17.3B | 31.2× | 12.3× | 1.9× | 6.8% | — | 6.3% | 6.7% | 5.4% | -0.1× | 78 |
| NYT | $11.2B | 33.2× | 21.2× | 4.0× | 9.2% | — | 12.2% | 16.9% | 16.9% | -0.5× | 152 |
| MH | $2.7B | 73.0× | 7.8× | 1.3× | 0.1% | 80.9% | 1.7% | 4.9% | 1.1% | 3.6× | 14 |
| WLY | $2.6B | 12.4× | 7.7× | 1.6× | -0.1% | 74.3% | 13.2% | 26.1% | 14.5% | 1.4× | 58 |
| CMPR | $1.5B | 15.9× | 8.8× | 0.4× | 9.8% | 46.3% | 2.6% | -19.4% | 8.6% | 4.2× | 35 |
| WBTN | $1.3B | — | — | 0.9× | 2.5% | 23.3% | -25.0% | -29.6% | -29.6% | — | 20 |
| DLX | $1.1B | 12.7× | 6.6× | 0.5× | 0.5% | 53.0% | 3.8% | 12.1% | 3.9% | 3.8× | 49 |
| TDAY | $909M | — | 12.8× | 0.4× | -8.3% | 38.7% | 0.1% | 1.1% | 0.2% | 6.3× | 36 |
| DJCO | $866M | 7.7× | 86.4× | 9.9× | 25.4% | — | — | 28.7% | 28.7% | -2.1× | 21 |
| SCHL | $722M | 16.8× | 10.6× | 0.5× | -2.7% | 56.4% | 3.6% | 7.6% | 6.9% | -1.0× | 28 |
| EBF | $551M | 13.1× | 8.4× | 1.4× | -0.6% | 30.7% | 10.9% | 13.8% | 13.8% | -0.6× | 33 |
| ACCO | $402M | 9.9× | 10.4× | 0.3× | -8.5% | 32.8% | 2.7% | 6.2% | 2.8% | 7.0× | 36 |
| QUAD | $396M | 14.3× | 4.1× | 0.2× | -9.4% | 21.6% | 1.1% | 21.0% | 5.4% | 1.8× | 21 |
| PMTS | $304M | 21.0× | 7.4× | 0.6× | 13.1% | 31.3% | 2.8% | -86.3% | 5.6% | 3.4× | 15 |
Peers = companies sharing MH's sector (Miscellaneous Publishing) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 15 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $246.3M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 3 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 1%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 3 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 3 positive fiscal years (FY2024, FY2025, FY2026). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $13.88 today, the market must believe free cash flow compounds 4.1%/yr for a decade (off $325.2M on the 3-yr avg basis).
On the basis ($314.0M) the requirement is 4.5%/yr. Shares issued to employees are added back in operating cash flow, so this basis treats them as free.
The market's 4.1% is more conservative than its 2-yr track record.
Default is 10.0% — this company's computed cost of capital (published default — this company's cost of capital could not be computed), the same rate the Analysis tab discounts at.
2-stage DCF · 0.19B shares (market data) · net debt $2.32B
mean 107.9% · volatility σ 233% · implied rate exceeded in 1/2 yrs
Central path = implied 4.1%/yr growth; shaded band = ±1σ (233%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $253.5M covers the $13.2M due within a year 19.2× over. Scheduled principal only (excludes interest & revolver draws). As of 2026-03-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest expense isn't separately reported — often netted into “other income (expense), net.”
Cash of $253.5M fully covers short-term debt of $13.2M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-10-29
How a revenue dollar becomes profit — FY2026
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | $2.10B 100.0% | $2.10B 100.0% | $1.96B 100.0% |
| Gross Profit | $1.70B 80.9% | $1.68B 79.9% | $1.54B 78.6% |
| Research & Development | $276.3M 13.1% | $284.4M 13.5% | $263.4M 13.4% |
| Selling, General & Admin | $369.0M 17.5% | $345.2M 16.4% | $331.7M 16.9% |
| Total Operating Expenses | $1.42B 67.8% | $1.37B 65.3% | $1.38B 70.6% |
| Operating Income | $276.8M 13.2% | $306.8M 14.6% | $155.3M 7.9% |
| Pretax Income | $43.8M 2.1% | $10.6M 0.5% | -$167.7M -8.6% |
| Income Tax Expense | $8.5M 0.4% | $96.5M 4.6% | $25.3M 1.3% |
| Net Income | $78.7M 3.7% | -$85.8M -4.1% | -$193.0M -9.8% |
| Per Share | |||
| EPS (Basic) | $0.19 | -$0.52 | -$1.16 |
| EPS (Diluted) | $0.19 | -$0.52 | -$1.16 |
| Weighted Avg Shares (Basic) | 183.5M | 166.6M | 166.6M |
| Weighted Avg Shares (Diluted) | 183.7M | 166.6M | 166.6M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-29
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
ROE 5% against ROIC 1% — 4% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 7.0% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Gross Profit | 78.6 | 79.9 | 80.9 |
| R&D | 13.4 | 13.5 | 13.1 |
| SG&A | 16.9 | 16.4 | 17.5 |
| Operating Income | 7.9 | 14.6 | 13.2 |
| Income Tax | 1.3 | 4.6 | 0.4 |
| Net Income | -9.8 | -4.1 | 3.7 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on MH: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Earns 0.95pts above its cost of capital, without much margin of safety.
| Period | ROIC | Cost of capital | Spread |
|---|---|---|---|
| FY2024 | 29.5% | 5.1% (today's — no rate published for this year) | 24.4pts |
| FY2025 | 6.7% | 5.1% (today's — no rate published for this year) | 1.6pts |
| FY2026 | 6.1% | 5.1% (today's — no rate published for this year) | 1.0pts |
| Now | 1.1% | 5.1% | -4.0pts |
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2024 | 78.6% | 7.9% | -9.8% |
| FY2025 | 79.9% | 14.6% | -4.1% |
| FY2026 | 80.9% | 13.2% | 1.7% |
Leverage and buybacks account for 4 points of the 5% return on equity in FY2026. The business earns 1% on the capital it employs; the rest is balance sheet.
ROE is on average equity; ROIC is NOPAT over average invested capital (debt plus equity less excess cash). The gap is not a single adjustment.
$2.5B of goodwill — 79% of invested capital. The gap is what was paid above the fair value of what was bought; it is real capital shareholders provided, so neither bar is the whole answer. With goodwill over half the base, the ex-goodwill figure divides by a small remainder and moves sharply — read it as a direction, not a precise rate.
ROIC ex-goodwill is 28.27% against 6.04% reported — the return is earned on a capital base inflated by what was paid for acquisitions, not by the operating business alone.
Fewer than three profitable years with a cash flow statement, so cash conversion cannot be judged.
No material counter-signal in the checked set: FCF / net income over 3 and 5 years, Sloan accruals, SBC as a share of revenue, SBC as a share of operating cash flow, SBC-adjusted free cash flow, free cash flow per diluted share, buybacks against SBC issued, capex vs depreciation, free cash flow against revenue, share count since the first year on file, cash conversion cycle (DSO, DIO, DPO), receivables growth against revenue growth.
Missing from our data, so excluded from this answer: 3 years of cash flow.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Ladder as of 2026-03-31 (10-K); cash from the 2026-03-31 balance sheet; FCF from FY2026.
Balance sheet at 2026-03-31. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: interest_expense.
At $13.88, free cash flow must compound 4.28%/yr for 10 years. It has done 26.38%/yr over 2 years.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2025 | 273.0% | 4.3% |
| FY2026 | −57.2% | 4.3% |
The cost of capital could not be computed for this company, so the requirement is solved at the published 10% default — a different rate would move it materially.
Last reported position per insider, carried forward. Steps can be a holding disclosed for the first time rather than a trade.
| Date | Insider | What it was | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-11 | Alvaro Felicia Director | Grant | 16,086 | $0.00 | $0 |
| 2026-08-11 | Reinemund Steven Director | Grant | 16,086 | $0.00 | $0 |
| 2026-08-11 | Allen Simon Jonathan Director | Grant | 16,086 | $0.00 | $0 |
| 2026-08-11 | Subramanian Guhan Director | Grant | 16,086 | $0.00 | $0 |
| 2026-06-15 | Moyer Philip D |
Every row is classified by what it MEANT, not by its SEC code. A code is not a meaning: code P (“purchase”) also covers dividend reinvestment and employee stock purchase plans, and code S (“sale”) also covers 10b5-1 plan sales scheduled months earlier and option exercises sold the same day.
Across 30 days of all filings, $5.08bn of insider selling contained $3.50bn of plan sales and $0.46bn of exercise-and-sell. Only 29% was discretionary. Reading an unclassified feed badly overstates how much insiders decided.
Buys and sales are counted separately and never netted. They are different decisions by different people; a company where one officer bought while another sold is not “neutral”.
The holding line carries each insider's last reported position forward, so it shows the total held rather than a sawtooth of whoever traded that day. It covers only insiders who filed in the window.
“Filed late” counts calendar days past the two-business-day deadline with five days' grace, so a Thursday or Friday trade crossing a weekend is never flagged. It describes the company's filing discipline, not the trade.
Insider activity is descriptive. Nothing here is investment advice.
| Open-market buy |
| 22,421 |
| $11.12 |
| $249k |
| 2026-04-01 | Tiska Tracey EVP & CHRO | Grant | 36,842 | $0.00 | $0 |
| 2026-04-01 | Van Dam Brian Keith Chief Accounting Officer | Grant | 8,473 | $0.00 | $0 |
| 2026-04-01 | Stafford David B EVP, GC & Secretary | Grant | 36,842 | $0.00 | $0 |
| 2026-04-01 | Sallmann Robert EVP & CFO | Grant | 86,842 | $0.00 | $0 |
| 2026-04-01 | Cortese David EVP & CDIO | Grant | 42,105 | $0.00 | $0 |
| 2026-02-17 | Reinemund Steven Director | Open-market buyindirect | 58,000 | $13.70 | $795k |
| 2026-02-17 | 3 co-filers See Remark | Grant | 108,381 | $13.84 | $1.5m |
| 2026-02-17 | 3 co-filers See Remark | Grant | 108,381 | $0.00 | $0 |
| 2026-02-09 | 3 co-filers See Remark | Grant4d late | 277,585 | $0.00 | $0 |
| 2025-11-14 | Reinemund Steven Director | Open-market buyindirect | 15,710 | $15.03 | $236k |